Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q1A0
Term | Name | Level | Count |
---|---|---|---|
GO:0006417 | regulation of translation | 6 | 2 |
GO:0009889 | regulation of biosynthetic process | 4 | 2 |
GO:0009891 | positive regulation of biosynthetic process | 5 | 2 |
GO:0009893 | positive regulation of metabolic process | 4 | 2 |
GO:0010468 | regulation of gene expression | 5 | 2 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 2 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6 | 2 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 2 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 2 |
GO:0010628 | positive regulation of gene expression | 6 | 2 |
GO:0019222 | regulation of metabolic process | 3 | 2 |
GO:0031323 | regulation of cellular metabolic process | 4 | 2 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 2 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 2 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6 | 2 |
GO:0034248 | regulation of amide metabolic process | 5 | 2 |
GO:0034250 | positive regulation of amide metabolic process | 6 | 2 |
GO:0045727 | positive regulation of translation | 7 | 2 |
GO:0048518 | positive regulation of biological process | 3 | 2 |
GO:0048522 | positive regulation of cellular process | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 2 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 2 |
GO:0051246 | regulation of protein metabolic process | 5 | 2 |
GO:0051247 | positive regulation of protein metabolic process | 6 | 2 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0080090 | regulation of primary metabolic process | 4 | 2 |
GO:2000112 | obsolete regulation of cellular macromolecule biosynthetic process | 6 | 2 |
GO:2000765 | regulation of cytoplasmic translation | 7 | 2 |
GO:2000767 | positive regulation of cytoplasmic translation | 8 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003727 | single-stranded RNA binding | 5 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 11 |
GO:0008270 | zinc ion binding | 6 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043169 | cation binding | 3 | 11 |
GO:0045182 | translation regulator activity | 1 | 2 |
GO:0046872 | metal ion binding | 4 | 11 |
GO:0046914 | transition metal ion binding | 5 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004540 | RNA nuclease activity | 4 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 350 | 352 | PF00675 | 0.564 |
CLV_NRD_NRD_1 | 415 | 417 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 476 | 478 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 502 | 504 | PF00675 | 0.471 |
CLV_NRD_NRD_1 | 55 | 57 | PF00675 | 0.349 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.428 |
CLV_PCSK_KEX2_1 | 329 | 331 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.575 |
CLV_PCSK_KEX2_1 | 417 | 419 | PF00082 | 0.484 |
CLV_PCSK_KEX2_1 | 442 | 444 | PF00082 | 0.541 |
CLV_PCSK_KEX2_1 | 476 | 478 | PF00082 | 0.495 |
CLV_PCSK_KEX2_1 | 502 | 504 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 55 | 57 | PF00082 | 0.349 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.332 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.349 |
CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.496 |
CLV_PCSK_PC1ET2_1 | 329 | 331 | PF00082 | 0.524 |
CLV_PCSK_PC1ET2_1 | 417 | 419 | PF00082 | 0.484 |
CLV_PCSK_PC1ET2_1 | 442 | 444 | PF00082 | 0.541 |
CLV_PCSK_PC1ET2_1 | 67 | 69 | PF00082 | 0.422 |
CLV_PCSK_PC1ET2_1 | 82 | 84 | PF00082 | 0.497 |
CLV_PCSK_PC7_1 | 51 | 57 | PF00082 | 0.484 |
CLV_PCSK_SKI1_1 | 360 | 364 | PF00082 | 0.498 |
CLV_PCSK_SKI1_1 | 418 | 422 | PF00082 | 0.471 |
CLV_PCSK_SKI1_1 | 445 | 449 | PF00082 | 0.613 |
CLV_PCSK_SKI1_1 | 539 | 543 | PF00082 | 0.536 |
DOC_CYCLIN_RxL_1 | 536 | 543 | PF00134 | 0.526 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 62 | 69 | PF00134 | 0.480 |
DOC_MAPK_gen_1 | 329 | 338 | PF00069 | 0.440 |
DOC_MAPK_gen_1 | 476 | 485 | PF00069 | 0.445 |
DOC_MAPK_MEF2A_6 | 329 | 338 | PF00069 | 0.459 |
DOC_PP1_RVXF_1 | 550 | 557 | PF00149 | 0.570 |
DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.642 |
DOC_USP7_MATH_1 | 284 | 288 | PF00917 | 0.767 |
DOC_USP7_MATH_1 | 293 | 297 | PF00917 | 0.731 |
DOC_WW_Pin1_4 | 289 | 294 | PF00397 | 0.740 |
LIG_14-3-3_CanoR_1 | 102 | 106 | PF00244 | 0.599 |
LIG_14-3-3_CanoR_1 | 174 | 180 | PF00244 | 0.459 |
LIG_14-3-3_CanoR_1 | 271 | 276 | PF00244 | 0.767 |
LIG_14-3-3_CanoR_1 | 310 | 320 | PF00244 | 0.678 |
LIG_14-3-3_CanoR_1 | 350 | 356 | PF00244 | 0.631 |
LIG_14-3-3_CanoR_1 | 360 | 368 | PF00244 | 0.432 |
LIG_14-3-3_CanoR_1 | 445 | 452 | PF00244 | 0.664 |
LIG_14-3-3_CanoR_1 | 83 | 88 | PF00244 | 0.780 |
LIG_APCC_ABBA_1 | 470 | 475 | PF00400 | 0.516 |
LIG_BRCT_BRCA1_1 | 558 | 562 | PF00533 | 0.613 |
LIG_Clathr_ClatBox_1 | 9 | 13 | PF01394 | 0.803 |
LIG_FHA_1 | 231 | 237 | PF00498 | 0.539 |
LIG_FHA_1 | 361 | 367 | PF00498 | 0.459 |
LIG_FHA_1 | 465 | 471 | PF00498 | 0.390 |
LIG_FHA_1 | 532 | 538 | PF00498 | 0.596 |
LIG_FHA_1 | 556 | 562 | PF00498 | 0.554 |
LIG_FHA_2 | 290 | 296 | PF00498 | 0.745 |
LIG_FHA_2 | 457 | 463 | PF00498 | 0.433 |
LIG_GBD_Chelix_1 | 433 | 441 | PF00786 | 0.440 |
LIG_LIR_Nem_3 | 357 | 362 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 390 | 396 | PF02991 | 0.512 |
LIG_LIR_Nem_3 | 490 | 495 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 559 | 565 | PF02991 | 0.648 |
LIG_LYPXL_S_1 | 491 | 495 | PF13949 | 0.395 |
LIG_LYPXL_yS_3 | 492 | 495 | PF13949 | 0.400 |
LIG_MYND_1 | 257 | 261 | PF01753 | 0.488 |
LIG_MYND_1 | 7 | 11 | PF01753 | 0.799 |
LIG_PCNA_PIPBox_1 | 530 | 539 | PF02747 | 0.599 |
LIG_PCNA_yPIPBox_3 | 525 | 537 | PF02747 | 0.624 |
LIG_Pex14_2 | 382 | 386 | PF04695 | 0.467 |
LIG_SH2_PTP2 | 322 | 325 | PF00017 | 0.661 |
LIG_SH2_STAP1 | 368 | 372 | PF00017 | 0.474 |
LIG_SH2_STAT3 | 527 | 530 | PF00017 | 0.661 |
LIG_SH2_STAT5 | 258 | 261 | PF00017 | 0.679 |
LIG_SH2_STAT5 | 322 | 325 | PF00017 | 0.656 |
LIG_SH2_STAT5 | 342 | 345 | PF00017 | 0.240 |
LIG_SH2_STAT5 | 368 | 371 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 372 | 375 | PF00017 | 0.400 |
LIG_SH2_STAT5 | 419 | 422 | PF00017 | 0.557 |
LIG_SH2_STAT5 | 497 | 500 | PF00017 | 0.447 |
LIG_SH3_3 | 314 | 320 | PF00018 | 0.697 |
LIG_TRAF2_1 | 11 | 14 | PF00917 | 0.801 |
LIG_TRAF2_1 | 91 | 94 | PF00917 | 0.659 |
LIG_TYR_ITIM | 121 | 126 | PF00017 | 0.624 |
LIG_TYR_ITSM | 355 | 362 | PF00017 | 0.375 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.784 |
MOD_CK1_1 | 274 | 280 | PF00069 | 0.759 |
MOD_CK1_1 | 287 | 293 | PF00069 | 0.603 |
MOD_CK1_1 | 354 | 360 | PF00069 | 0.398 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.688 |
MOD_CK1_1 | 426 | 432 | PF00069 | 0.545 |
MOD_CK2_1 | 338 | 344 | PF00069 | 0.486 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.570 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.769 |
MOD_GlcNHglycan | 269 | 274 | PF01048 | 0.708 |
MOD_GlcNHglycan | 282 | 285 | PF01048 | 0.568 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.656 |
MOD_GlcNHglycan | 425 | 428 | PF01048 | 0.547 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.437 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.406 |
MOD_GSK3_1 | 168 | 175 | PF00069 | 0.265 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.770 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.748 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.524 |
MOD_GSK3_1 | 289 | 296 | PF00069 | 0.613 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.689 |
MOD_GSK3_1 | 497 | 504 | PF00069 | 0.530 |
MOD_GSK3_1 | 517 | 524 | PF00069 | 0.338 |
MOD_LATS_1 | 228 | 234 | PF00433 | 0.578 |
MOD_N-GLC_1 | 287 | 292 | PF02516 | 0.710 |
MOD_N-GLC_1 | 32 | 37 | PF02516 | 0.744 |
MOD_N-GLC_1 | 351 | 356 | PF02516 | 0.667 |
MOD_N-GLC_2 | 225 | 227 | PF02516 | 0.491 |
MOD_N-GLC_2 | 64 | 66 | PF02516 | 0.447 |
MOD_NEK2_1 | 137 | 142 | PF00069 | 0.510 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.364 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.401 |
MOD_NEK2_1 | 396 | 401 | PF00069 | 0.497 |
MOD_NEK2_1 | 501 | 506 | PF00069 | 0.530 |
MOD_NEK2_2 | 497 | 502 | PF00069 | 0.575 |
MOD_PIKK_1 | 153 | 159 | PF00454 | 0.426 |
MOD_PIKK_1 | 16 | 22 | PF00454 | 0.798 |
MOD_PIKK_1 | 28 | 34 | PF00454 | 0.755 |
MOD_PK_1 | 83 | 89 | PF00069 | 0.686 |
MOD_PKA_1 | 502 | 508 | PF00069 | 0.585 |
MOD_PKA_2 | 101 | 107 | PF00069 | 0.605 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.453 |
MOD_PKA_2 | 265 | 271 | PF00069 | 0.781 |
MOD_PKA_2 | 501 | 507 | PF00069 | 0.472 |
MOD_PKB_1 | 416 | 424 | PF00069 | 0.568 |
MOD_PKB_1 | 443 | 451 | PF00069 | 0.650 |
MOD_Plk_1 | 397 | 403 | PF00069 | 0.468 |
MOD_Plk_1 | 411 | 417 | PF00069 | 0.449 |
MOD_Plk_2-3 | 265 | 271 | PF00069 | 0.715 |
MOD_Plk_4 | 338 | 344 | PF00069 | 0.511 |
MOD_Plk_4 | 354 | 360 | PF00069 | 0.599 |
MOD_ProDKin_1 | 289 | 295 | PF00069 | 0.741 |
TRG_DiLeu_BaLyEn_6 | 536 | 541 | PF01217 | 0.623 |
TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.620 |
TRG_ENDOCYTIC_2 | 322 | 325 | PF00928 | 0.661 |
TRG_ENDOCYTIC_2 | 359 | 362 | PF00928 | 0.548 |
TRG_ENDOCYTIC_2 | 492 | 495 | PF00928 | 0.454 |
TRG_ER_diArg_1 | 307 | 310 | PF00400 | 0.787 |
TRG_ER_diArg_1 | 349 | 351 | PF00400 | 0.686 |
TRG_ER_diArg_1 | 415 | 418 | PF00400 | 0.481 |
TRG_ER_diArg_1 | 501 | 503 | PF00400 | 0.564 |
TRG_ER_diArg_1 | 54 | 56 | PF00400 | 0.348 |
TRG_ER_diArg_1 | 72 | 74 | PF00400 | 0.405 |
TRG_NLS_Bipartite_1 | 67 | 86 | PF00514 | 0.443 |
TRG_Pf-PMV_PEXEL_1 | 360 | 364 | PF00026 | 0.533 |
TRG_Pf-PMV_PEXEL_1 | 418 | 422 | PF00026 | 0.473 |
TRG_Pf-PMV_PEXEL_1 | 539 | 543 | PF00026 | 0.536 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIN4 | Leptomonas seymouri | 74% | 100% |
A0A1X0P496 | Trypanosomatidae | 53% | 100% |
A0A3Q8IKH2 | Leishmania donovani | 96% | 100% |
A0A3R7MHM2 | Trypanosoma rangeli | 53% | 100% |
A4HPI5 | Leishmania braziliensis | 85% | 99% |
A4IDA7 | Leishmania infantum | 96% | 100% |
D0A8E8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9AT97 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5DA56 | Trypanosoma cruzi | 54% | 100% |